PF-Atlas › Clinical Trials › NCT00846053
FDG-PET Imaging in Young Cystic Fibrosis Patients
FDG-PET · Not specified
Registry ID
NCT00846053
Phase
Not specified
Status
Completed
Drug / intervention
FDG-PET
Sponsor
Washington University School of Medicine
Start
2009-02
Enrollment
21
Locations
1
About this trial
The purpose of this research is to determine how a person's lungs will uptake \[18F\]fluorodeoxyglucose (FDG), as measured with positron emission tomography (PET) scanning in young cystic fibrosis (CF) patients.
Explore related
Related trials
Medical disclaimer. This page summarizes public trial data for NCT00846053 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.